SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2020

Revenue by payor class as a percentage of total net service revenue is as follows:


	For the Three-Month Periods Ended March 31,
	2020		2019
Home Health:
Medicare	41	%	46	%
Non-Medicare - Episodic-based	6	%	9	%
Non-Medicare - Non-episodic based	14	%	12	%
Hospice (1):
Medicare	33	%	28	%
Non-Medicare	2	%	1	%
Personal Care	4	%	4	%
	100	%	100	%
(1) Acquired Compassionate Care Hospice on February 1, 2019, RoseRock Healthcare on April 1, 2019 and Asana Hospice on January 1, 2020.

Schedule of Fair Value of Financial Instruments

The following details our financial instruments where the carrying value and the fair value differ (amounts in millions):


	Fair Value at Reporting Date Using
Financial Instrument	Carrying Value as of March 31, 2020		Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Long-term obligations	$	391.2	$	—	$	383.6	$	—

Schedule of Weighted-Average Shares Outstanding

The following table sets forth, for the periods indicated, shares used in our computation of the weighted-average shares outstanding, which are used to calculate our basic and diluted net income attributable to Amedisys, Inc. common stockholders (amounts in thousands):


	For the Three- Month Periods Ended March 31,
	2020	2019
Weighted average number of shares outstanding - basic	32,331	32,001
Effect of dilutive securities:
Stock options	594	559
Non-vested stock and stock units	309	333
Weighted average number of shares outstanding - diluted	33,234	32,893
Anti-dilutive securities	57	148